Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sunesis Pharmaceuticals

5.32
+0.0000
Volume:- -
Turnover:- -
Market Cap:27.52M
PE:-0.85
High:5.32
Open:5.32
Low:5.32
Close:5.32
Loading ...

BRIEF-Yair Schindel Reports 19.98% Stake In Sunesis Pharmaceuticals As Of Feb 24

Reuters
·
02 Mar 2021

Viracta Therapeutics Announces Closing of Merger with Sunesis Pharmaceuticals and $65M Private Placement

PR Newswire
·
25 Feb 2021

Mid-Day Market Update: US Stocks Turn Higher; Systemax Shares Fall Following Q4 Earnings

Benzinga
·
25 Feb 2021

Sunesis Pharmaceuticals upgraded to outperform from perform at Oppenheimer

Dow Jones
·
23 Feb 2021

Sunesis Pharma Climbs After Viracta Poised To Nab US Patent For Nanatinostat/Valganciclovir Regime

Benzinga
·
17 Feb 2021

Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma

PR Newswire
·
16 Feb 2021

Viracta Therapeutics to Participate in Upcoming Virtual Investor Conferences

PR Newswire
·
12 Feb 2021

MERGER INVESTIGATION: Halper Sadeh LLP Investigates CPAH, HMSY, SNSS, EIDX; Shareholders Are Encouraged to Contact the Firm

ACCESSWIRE
·
09 Jan 2021

ALERT: Halper Sadeh LLP Investigates TDY, TCP, BEAT, HCAP, SNSS; Shareholders Are Encouraged to Contact the Firm

PR Newswire
·
06 Jan 2021

BRIEF-Laurence Lytton Reports 8.8% Passive Stake In Sunesis Pharmaceuticals

Reuters
·
05 Jan 2021

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers - PNM, TNAV, SNSS, ZAGG, ELY

PR Newswire
·
31 Dec 2020

SUNESIS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS

Business Wire
·
30 Dec 2020

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - AKER, INFO, SNSS, WORK, WDR

PR Newswire
·
20 Dec 2020

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm – SNSS, WORK, WDR, ANH

GlobeNewswire
·
12 Dec 2020

BRIEF-Viracta Therapeutics Announces Presentation Of Updated Phase 2 Data At Ash 2020 And Productive Outcome Of Its Recent End Of Phase 2 Meeting With FDA

Reuters
·
07 Dec 2020

BRIEF-Viracta Therapeutics Says Complete Responses Observed Across Multiple Ebv+ Lymphoma Subtypes In Phase 2 Study

Reuters
·
07 Dec 2020

ALERT: Halper Sadeh LLP Encourages INFO, SNSS, and WORK Shareholders to Contact the Firm

ACCESSWIRE
·
05 Dec 2020

SUNESIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Sunesis Pharmaceuticals, Inc. - SNSS

Business Wire
·
04 Dec 2020

Lifshitz Law Firm, P.C. Announces Investigation of CLCT, FBM, SNSS and WORK

ACCESSWIRE
·
04 Dec 2020